Cargando…

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study

BACKGROUND: There are few clinical trials that assess the efficacy of antihistamines in very young children. Rupatadine is a second-generation antihistamine indicated for the treatment of allergic rhinitis (AR) and urticaria. In this study, AR symptoms were evaluated before and after daily 1 mg/mL r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santamaría, Eva, Izquierdo, Iñaki, Valle, Marta, Vermeulen, Jan, Potter, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128281/ https://www.ncbi.nlm.nih.gov/pubmed/30214250 http://dx.doi.org/10.2147/JAA.S164632

Ejemplares similares

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
por: Santamaria, Eva, et al.
Publicado: (2021)

Population pharmacokinetic modelling of rupatadine solution in 6–11 year olds and optimisation of the experimental design in younger children
por: Santamaría, Eva, et al.
Publicado: (2017)

Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis
por: Izquierdo, Iñaki, et al.
Publicado: (2013)

PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children
por: Valle, Marta, et al.
Publicado: (2014)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)

O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)
por: Potter, Paul, et al.
Publicado: (2014)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes
por: Liu, Yu, et al.
Publicado: (2022)

FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis
por: de Godoy Mion, Olavo, et al.
Publicado: (2015)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
por: Marmouz, Farid, et al.
Publicado: (2011)

Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
por: Täubel, Jörg, et al.
Publicado: (2016)

Rupatadine
por: Kaur, Manpreet, et al.
Publicado: (2013)

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study
por: Dakhale, Ganesh, et al.
Publicado: (2016)

Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013)

Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Ellis, Anne K., et al.
Publicado: (2021)

Providing open-label placebos remotely—A randomized controlled trial in allergic rhinitis
por: Kube, Tobias, et al.
Publicado: (2021)

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
por: Lukat, KF, et al.
Publicado: (2013)

Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients’ Quality of Life: a Prospective, Non-interventional Trial
por: Metz, Martin, et al.
Publicado: (2015)

Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2016)

Correction: Providing open-label placebos remotely—A randomized controlled trial in allergic rhinitis
por: Kube, Tobias, et al.
Publicado: (2021)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
Publicado: (2015)

Efficacy and safety of two Ayurvedic dosage forms for allergic rhinitis: Study protocol for an open-label randomized controlled trial
por: Dahanayake, Jeevani Maheshika, et al.
Publicado: (2020)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2011)

Allergic rhinitis
por: Small, Peter, et al.
Publicado: (2018)

Clinical Efficacy and Safety of a Combined Loratadine-Betamethasone Oral Solution in the Treatment of Severe Pediatric Perennial Allergic Rhinitis
por: de Morales, Teolinda Mendoza, et al.
Publicado: (2009)

Allergen Challenge Chamber: an innovative solution in allergic rhinitis diagnosis
por: Krzych-Fałta, Edyta, et al.
Publicado: (2015)

Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial
por: Zhao, Jingyi, et al.
Publicado: (2019)

Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults
por: Shargorodsky, Josef, et al.
Publicado: (2015)

Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial
por: Nehrig, Julian, et al.
Publicado: (2023)

Management of Rhinitis: Allergic and Non-Allergic
por: Tran, Nguyen P, et al.
Publicado: (2011)

Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects
por: Shamizadeh, Soja, et al.
Publicado: (2014)

Management of allergic rhinitis
por: Solelhac, Geoffroy, et al.
Publicado: (2014)

Acute allergic rhinitis
por: Green, Robin J., et al.
Publicado: (2020)

Probiotics in allergic rhinitis
por: Nogueira, Janaina Cândida Rodrigues, et al.
Publicado: (2015)

Local allergic rhinitis()
por: Mello Junior, João Ferreira de
Publicado: (2016)

Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial
por: Prakash, Vaidya B, et al.
Publicado: (2023)

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
por: Che, Yanlu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_72dpkgrctilmtrjqepjomqt07a